DK1696907T3 - PDK-1/AKT Signalinhibitorer - Google Patents

PDK-1/AKT Signalinhibitorer

Info

Publication number
DK1696907T3
DK1696907T3 DK04816902.3T DK04816902T DK1696907T3 DK 1696907 T3 DK1696907 T3 DK 1696907T3 DK 04816902 T DK04816902 T DK 04816902T DK 1696907 T3 DK1696907 T3 DK 1696907T3
Authority
DK
Denmark
Prior art keywords
pdk
akt signal
signal inhibitors
inhibitors
akt
Prior art date
Application number
DK04816902.3T
Other languages
Danish (da)
English (en)
Inventor
Ching-Shih Chen
Original Assignee
Univ Ohio State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34576689&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1696907(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Ohio State Res Found filed Critical Univ Ohio State Res Found
Application granted granted Critical
Publication of DK1696907T3 publication Critical patent/DK1696907T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK04816902.3T 2003-10-03 2004-10-04 PDK-1/AKT Signalinhibitorer DK1696907T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50861903P 2003-10-03 2003-10-03
US50981403P 2003-10-08 2003-10-08
PCT/US2004/032723 WO2005044130A1 (en) 2003-10-03 2004-10-04 Pdk-1/akt signaling inhibitors

Publications (1)

Publication Number Publication Date
DK1696907T3 true DK1696907T3 (da) 2013-06-24

Family

ID=34576689

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04816902.3T DK1696907T3 (da) 2003-10-03 2004-10-04 PDK-1/AKT Signalinhibitorer

Country Status (9)

Country Link
EP (1) EP1696907B1 (enExample)
JP (1) JP4745971B2 (enExample)
KR (1) KR101217427B1 (enExample)
CN (1) CN1889949B (enExample)
CA (1) CA2566846C (enExample)
DK (1) DK1696907T3 (enExample)
ES (1) ES2420405T3 (enExample)
SI (1) SI1696907T1 (enExample)
WO (1) WO2005044130A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060079566A1 (en) 2003-10-03 2006-04-13 Ching-Shih Chen PDK-1/Akt signaling inhibitors
CA2613522A1 (en) 2005-06-27 2007-01-04 Exelixis, Inc. Imidazole based lxr modulators
JP2009519336A (ja) 2005-12-13 2009-05-14 ワイス ジベンゾナフチリジン誘導体およびそれらの使用方法
JP5399262B2 (ja) * 2006-12-08 2014-01-29 エグゼリクシス パテント カンパニー エルエルシー Ｌｘｒおよびｆｘｒのモジュレーター
US8039502B2 (en) 2007-07-24 2011-10-18 The Ohio State University Research Foundation Anti-infective agents against intracellular pathogens
US20120108823A1 (en) * 2009-04-22 2012-05-03 The Ohio State University Research Foundation Anti-francisella agents
DE102009043260A1 (de) 2009-09-28 2011-04-28 Merck Patent Gmbh Pyridinyl-imidazolonderivate
RU2432112C1 (ru) * 2010-05-27 2011-10-27 Федеральное государственное учреждение "Саратовский научно-исследовательский институт травматологии и ортопедии" Министерства здравоохранения и социального развития Российской Федерации (ФГУ "СарНИИТО" Минздравсоцразвития России) Способ прогнозирования послеоперационных осложнений у больных с дегенеративно-дистрофическими поражениями суставов нижних конечностей
DE102010049877A1 (de) * 2010-11-01 2012-05-03 Merck Patent Gmbh 7-((1,2,3)Triazol-4-yl)-pyrrolo(2,3) pyrazinderivate
CA2818871A1 (en) * 2010-11-24 2012-05-31 The Ohio State University Research Foundation Integrin-linked kinase inhibitors
US10028933B2 (en) * 2015-07-22 2018-07-24 Ohio State Innovation Foundation Compositions and methods for inhibiting the growth of multi-drug resistant microbes
CN116462606B (zh) * 2022-01-12 2025-11-28 南京宁丹新药技术股份有限公司 一类酰胺衍生化合物及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL104311A (en) 1992-02-05 1997-07-13 Fujisawa Pharmaceutical Co Pyrazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
US5401765A (en) * 1993-11-30 1995-03-28 G. D. Searle 1,4,5-triphenyl pyrazolyl compounds for the treatment of inflammation and inflammation-related disorders
KR100263817B1 (ko) * 1993-11-30 2000-08-16 윌리암스 로저 에이 염증치료용 치환 피라졸일벤젠술폰아미드
US5660273A (en) * 1994-07-13 1997-08-26 Centrix, Inc. Single patient dose medicament dispenser with applicator
AU2003230836A1 (en) * 2002-04-08 2003-10-27 The Ohio State University Research Foundation Compounds and methods for inducing apoptosis in proliferating cells
US7201577B2 (en) * 2002-04-24 2007-04-10 Gosmile, Inc. Tooth whitener applicator and method

Also Published As

Publication number Publication date
EP1696907B1 (en) 2013-04-17
KR101217427B1 (ko) 2013-01-02
WO2005044130A1 (en) 2005-05-19
CN1889949B (zh) 2010-06-16
EP1696907A1 (en) 2006-09-06
EP1696907A4 (en) 2007-09-05
JP2007527408A (ja) 2007-09-27
ES2420405T3 (es) 2013-08-23
CA2566846C (en) 2012-08-28
CN1889949A (zh) 2007-01-03
JP4745971B2 (ja) 2011-08-10
KR20060108651A (ko) 2006-10-18
CA2566846A1 (en) 2005-05-19
WO2005044130A9 (en) 2005-09-15
SI1696907T1 (sl) 2013-12-31

Similar Documents

Publication Publication Date Title
DE602004018837D1 (de) Ptidase-iv-inhibitoren
ATE452891T1 (de) Pyrimidopyrimidone als kinaseinhibitoren
ATE505471T1 (de) Azaindol-kinaseinhibitoren
DE60320933D1 (de) Rho-kinase inhibitoren
ATE445614T1 (de) Phosphatidylinositol 3-kinase inhibitoren
DE502004002737D1 (de) Fahrzeugprüfstand
FI113616B (fi) Instrumentti
DE602004003970D1 (de) Audiovorrichtung
DE60336123D1 (de) Heftinstrument
DE60328402D1 (de) Tonsignalerzeugung
EP1660436A4 (en) cathepsin inhibitors
DE50308254D1 (de) Messgerät
DE602004004230D1 (de) Klasse-D Verstärker
DE602004024638D1 (de) Bildaufnahmevorrichtung
DE602004013236D1 (de) Messgerät
NO20031114L (no) Signallys
DE502004010607D1 (de) Auslösesignalgeber
ITRM20030318A1 (it) Trasduttore ultracustico capacitivo microlavorato e
DK1696907T3 (da) PDK-1/AKT Signalinhibitorer
ATA12962003A (de) Schallabsorbierendes element
DE60328233D1 (de) Sulfamatbenzothiophenderivate als steroidsulfataseinhibitoren
DE60313327D1 (de) Druckaufnehmer
DE602004019720D1 (de) Platteneinheit
DE602004008130D1 (de) Messuhr
DE602004029066D1 (de) Datenträgereinrichtung